WEAVER GREGORY L 4
4 · Altimmune, Inc. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
WEAVER GREGORY L
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001
2025-03-13$5.20/sh+10,000$51,996→ 10,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1950 to $5.1997, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.